Compare Dover Corp (DOV) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dover Corp vs Oruka Therapeutics Inc. Common Stock — how do they compare? Dover Corp trades at $193.31 (market cap $26.04B), while Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B). The key difference: Dover Corp is far larger — about 5.1× Oruka Therapeutics Inc. Common Stock's market cap, and Dover Corp pays a 1.09% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dover Corp for 74 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| DOV | ORKA | |
|---|---|---|
Market Cap | $26.04B | $5.08B |
Volume | 863,995 | 685,276 |
Sector | Industrials | Health |
52-Week High | $233.31 | $113.08 |
52-Week Low | $162.66 | $26.19 |
Typical Hold Time | 74 Days | 0 Days |
Enterprise Value | $27.54B | $4.21B |
Dividend Yield | 1.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dover Corporation (DOV) trades at $192.48, up 0.84% with a neutral technical signal. The company demonstrates strong fundamentals with consistent earnings beats, a 13.48% net margin, and robust cash flow. Recent acquisitions and product launches highlight growth initiatives. Analyst consensus is strongly bullish with a $243.20 price target representing 26% upside potential.
DOV presents a compelling investment case with solid profitability and positive analyst sentiment, though investors should monitor execution risks from recent acquisitions and industrial sector volatility. The stock's current valuation appears reasonable relative to growth prospects, supported by the company's Dividend King status and strong institutional backing.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dover Corp
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
